Quantcast
Latest Stories

Changing Diabetes

Diabetes medications that promote weight loss

By

Most patients diagnosed with type 2 diabetes are above their ideal weight. Excess weight, particularly around the waist, is a major cause of insulin resistance, a condition in which the body does not use insulin effectively causing glucose to build up in the blood instead of being absorbed by the cells. Over time, insulin resistance can lead to type 2 diabetes.

Losing weight greatly reduces the risk of developing type 2 diabetes and can help bring blood glucose under control in individuals who already have the disease. Individuals with type 2 diabetes who are overweight or obese are at increased risk of developing complications. Losing just a few pounds through exercise, eating well and taking the right medications can help control diabetes and reduce the risk for other health problems.

Some diabetes medications not only lower blood glucose but also have the added benefit of promoting weight loss. One of the common findings in early type 2 diabetes is hyperinsulinemia, a condition in which the pancreas secretes large amounts of insulin to counter insulin resistance to keep blood glucose within normal range. Insulin has been shown to act on the brain and produce hunger or stimulate appetite. Metformin prevents the pancreas from secreting too much insulin by increasing the body’s sensitivity to insulin and suppressing the release of glucose from the liver, thereby preventing blood glucose levels from rising too high and lowering appetite.

Liraglutide is a once-daily injectable medication for adults with type 2 diabetes mellitus that provides substantial reduction in HbA1c, a key measure of blood glucose control. It also has the added benefit of promoting weight loss by reducing appetite. Marketed under the brand name Victoza, it mimics the action of an intestinal hormone called GLP-1 that stimulates the beta cells in the pancreas to release insulin when blood sugar is too high after meals. GLP-1 also helps lower the amount of glucose produced by the liver.

A new study has shown that this innovative medication can induce and maintain weight loss in people who are obese or overweight with type 2 diabetes. The study involved 846 type 2 diabetes patients with an average weight of 106 kilograms (234 pounds) and mean BMI or body mass index of 37 (normal BMI range for adults is 18 to 24.9). Subjects were randomized 2:1:1 to receive liraglutide 3 mg and 1.8 mg or placebo in combination with diet modification and exercise.

After 56 weeks, subjects given the once-daily medication achieved an average weight loss of about 6 percent compared to 2 percent for those given placebo. More subjects on the medication achieved substantial weight loss compared to those on placebo. Starting from a baseline HbA1c of 8 percent, almost 70 percent of subjects treated with liraglutide achieved the HbA1c treatment target of 7 percent compared to 27 percent of subjects given placebo.

This study showed that it is possible to achieve both clinically significant weight loss and excellent glucose control with a single treatment in overweight or obese patients with type 2 diabetes.

DIABETES TRIVIA CONTEST: GLP-1 is a hormone secreted by the small intestine that helps stimulate insulin secretion. True or False? E-mail your answer to changingdiabetesph@gmail.com and get a chance to win a prize! Congratulations to Boyet Ignes! Your correct answer to the question in the July 20, 2013 column was chosen as this week’s winner in the Diabetes Trivia Contest. You will receive an e-mail on how to claim your prize.

Dr. Sjoberg A. Kho is a board-certified endocrinologist. The 7“Changing Diabetes” column commemorates the 92nd anniversary of insulin’s discovery. It aims to increase awareness on diabetes prevention, diagnosis and management. Novo Nordisk supports “Changing Diabetes.” Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. For questions or comments, e-mail changingdiabetesph@gmail.com.


Follow Us


Follow us on Facebook Follow on Twitter Follow on Twitter


Recent Stories:

Complete stories on our Digital Edition newsstand for tablets, netbooks and mobile phones; 14-issue free trial. About to step out? Get breaking alerts on your mobile.phone. Text ON INQ BREAKING to 4467, for Globe, Smart and Sun subscribers in the Philippines.

Tags: column , diabetes , health and wellness , hyperinsulinemia , Medicines , sjoberg a. kho , weight-loss

  • EdsonArantesDoNascimiento

    This is another marketing-hype (even outright deception) by the big pharmaceutical cos.,to feed their greed for profit!!!!This is a typical easy/fast way (w/c is a questionable red-flag & dangerous)to manage (you cannot fight it,bec.there’s still no cure) DM-2!!!! NOTHING BEATS HARD &SMART WORK TO MANAGE DM-2! LIFESTYLE CHANGE, EXERCISE (30MINS./DAY),EATING HEALTHY (WHOLE-FOODS),LOTS OF H2O (AT LEAST 8 250ML GLASSES/DAY),AND ABOVE ALL,PRAYER!!!!!



Copyright © 2014, .
To subscribe to the Philippine Daily Inquirer newspaper in the Philippines, call +63 2 896-6000 for Metro Manila and Metro Cebu or email your subscription request here.
Factual errors? Contact the Philippine Daily Inquirer's day desk. Believe this article violates journalistic ethics? Contact the Inquirer's Reader's Advocate. Or write The Readers' Advocate:
c/o Philippine Daily Inquirer Chino Roces Avenue corner Yague and Mascardo Streets, Makati City, Metro Manila, Philippines Or fax nos. +63 2 8974793 to 94
Advertisement
Advertisement

News

  • Drunk passenger triggers Bali hijack alert
  • Businesswoman allegedly killed by husband, brother-in-law
  • Roxas suspended from golf club for outburst over P5,000 guest fee
  • SC reschedules oath-taking of new lawyers
  • Ex-COA chief seeks bail after arrest for plunder
  • Sports

  • Guiao fined P100,000 for ‘mongoloid’ comment vs Meralco forward
  • Hawks and Grizzlies revel in home wins
  • Floyd: Manny’s power gone
  • Michael Phelps loses to Lochte in comeback meet
  • Sharapova advances to Stuttgart quarterfinals
  • Lifestyle

  • ‘Recovered’ Banksy works on display ahead of sale
  • Marinduque: Visiting the ‘palm of the ocean’
  • First at Vatican in 60 years
  • How Jing Monis Salon gave Krissy the pixie
  • Want to be a supermodel? Work on your inner beauty, says Joey Espino
  • Entertainment

  • Paul McCartney to play at Candlestick concert
  • Kristoffer Martin: from thug to gay teen
  • Has Ai Ai fallen deeply with ‘sireno?’
  • California court won’t review Jackson doctor case
  • Cris Villonco on play adapted from different medium
  • Business

  • PAL hailed for ban on shark fin cargo
  • BSP to change tint of P100 bill
  • Nielsen sees car buying boom in the Philippines
  • How author of best-seller exposed ‘one percent’ economic elite
  • Bangko Sentral readies new bank lending rules
  • Technology

  • Cloud strength helps Microsoft earnings top Street
  • Vatican announces hashtag for April 27 canonizations
  • Enrile in Masters of the Universe, Lord of the Rings?
  • Top Traits of Digital Marketers
  • No truth to viral no-visa ‘chronicles’
  • Opinion

  • Corruption not invincible after all
  • Editorial Cartoon, April 25, 2014
  • No deal, Janet
  • Like making Al Capone a witness vs his gang
  • MERS-CoV and mothers
  • Global Nation

  • Plane lands at Bali airport in suspected hijacking—Indonesia air force
  • Obama lands in Seoul as N. Korea nuclear test fears grow
  • Militant protests vs Obama, US set
  • Filipinos second-shortest in Southeast Asia
  • China welcomes PH apology
  • Marketplace